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Objective: The modified Fontan procedure, usually performed in children, is used
for the treatment of anomalies with a single functional ventricle. We reviewed our
experience with the modified Fontan procedure performed in the adult patient.
Methods: Between October 1973 and May 2001, the modified Fontan procedure was
performed on 132 adult patients (74 men, 58 women). Median age was 23 years
(range, 18 to 53 years). Diagnoses included tricuspid atresia in 34 patients (26%),
double-inlet left ventricle in 48 (36%), and complex lesions in 50 (38%). The
majority of patients (89%) had at least one prior palliative procedure; the most
common procedures were Blalock-Taussig shunt in 85 patients and Glenn anasto-
mosis in 31.
Results: Operations included an atriopulmonary connection in 74 patients, lateral
tunnel in 27, intra-atrial conduit in 14, right atrium-to-right ventricle in 9, extra-
cardiac conduit in 3, and other in 5. Overall early mortality was 8.3%. Mortality was
6.5% for operations performed after 1980. This is comparable to the mortality of the
modified Fontan procedure performed in children during the same time interval at
our institution. All 7 of the early deaths since 1980 occurred in the complex lesion
group. Morbidity included prolonged pleural effusion in 36 patients, atrial arrhyth-
mias in 25, reoperation for bleeding in 13, permanent pacemaker in 8, and stroke in
2. Mean follow-up was 9.1 years with a maximum of 21.2 years. Actuarial survival
for early survivors was 89% (84,95), 75% (67,84), and 68% (58,79) at 5, 10, and 15
years, respectively. Freedom from late reoperation was 89% (83,95), 85% (78,93),
and 80% (70,91) at 5, 10 and 15 years, respectively. The majority (90%) of present
survivors were New York Heart Association class I or II at follow-up.
Conclusions: In properly selected adult patients with functional single ventricle, the
modified Fontan procedure can be performed with early mortality similar to younger
patients. Early mortality is more likely with complex lesions. The majority of late
survivors have a good quality of life.
In 1971 Fontan and Baudet first described successful clinical bypass of theright ventricle, with separation of the pulmonary and systemic circulations,in a patient with tricuspid atresia.1 The technique described in this initialreport included a classic Glenn anastomosis, a pulmonary homograft valveinserted at the inferior vena cava–right atrial junction, and an aortic valvedhomograft from the right atrial appendage to the main pulmonary artery.
Independently, Kreutzer and colleagues described right ventricle bypass in a patient
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with tricuspid atresia in which the pulmonary annulus and
valve were detached from the right ventricular outflow tract
and connected to the right atrial appendage.2 Since these
initial reports, the operative technique has gone through
many technical modifications and has been applied to pa-
tients with a variety of functional single-ventricle diag-
noses. Since 1973, we have performed several modifications
of the Fontan procedure (MFP) in patients with tricuspid
atresia, double-inlet left ventricle, and other forms of com-
plex functional single ventricle. Historically, the operation
has been performed predominantly in children. The purpose
of this study was to examine the clinical course and out-
come of all adult patients who had an MFP performed at the
Mayo Clinic.
Patients and Methods
MFP was performed in 957 patients from October 31, 1973, to
April 24, 2001, at the Mayo Clinic in Rochester, Minnesota. One
hundred thirty-two of these patients (14%) were 18 years of age or
older. Medical records of these 132 adult patients were reviewed
for patient demographics, preoperative symptoms, operative pro-
cedure, pre- and postoperative hemodynamics, early and late mor-
bidity, and survival. Adult patients undergoing revision of a pre-
vious MFP were excluded from this study.
Seventy-four patients (56%) were men and 58 (44%) were
women. Median age at time of the MFP was 23 years (range, 18 to
53 years). The majority of patients (85%) were in New York Heart
Association (NYHA) functional class III or IV preoperatively.
Fifty patients (38%) were on preoperative digoxin, 20 (15%) were
on diuretic therapy, and 15 (11%) were on an antiarrhythmic agent.
Diagnoses were divided into three groups as seen in Table 1.
All of the patients in the complex lesion group had a functional
single ventricle or two ventricles unsuitable for ventricular septa-
tion. The subset of patients with double-outlet right ventricle
included asplenia and polysplenia syndromes, hypoplastic or strad-
dling atrioventricular valves, and crisscross hearts, all of which
had anomalies that precluded a two-ventricle repair.
A total of 193 palliative operations had been performed prior to
the MFP in 118 patients (89%) (Table 2). The two most common
procedures were Blalock-Taussig shunt (n  85) and Glenn anas-
tomosis (n  31). A Potts or Waterston anastomosis was per-
formed in 35 patients. Sixty patients had one previous operation,
46 had two, and 12 had three or more. Fourteen patients (11%) had
no cardiac operations prior to their MFP.
Prolonged pleural effusions were defined as effusions that
required chest tube drainage for more than 14 days. Atrial arrhyth-
mias included transient or persistent supraventricular tachycardia,
atrial fibrillation, and atrial flutter. Renal failure was defined as
occurring in patients who required hemodialysis.
The follow-up status of the patients was determined principally
by review of the patient records, written questionnaires, or tele-
phone interviews when necessary. Data reviewed included func-
tional status, any hospitalizations, cardiovascular events, and re-
operations. Death certificates, physician notes, and hospital notes
were reviewed in the event of a death.
Early mortality was defined as death occurring within 30 days
of operation or at any time during the operative hospitalization.
Survival statistics were performed using the Kaplan-Meier method
with the day of operation as the starting point.3 Ninety-five percent
confidence intervals were calculated for each survival estimate.
Survival curves were compared using the log-rank test. Factors
that affected survival were analyzed with the Cox proportional
hazards model.4 Continuous risk factors were dichotomized using
roughly the median or third quartile as a cut point. P values less
than .05 were considered statistically significant.
Results
All operations were performed through a median sternot-
omy utilizing cardiopulmonary bypass. The median cardio-
pulmonary bypass time was 138 minutes (range, 66 to 339
minutes). Aortic crossclamping was utilized in 121 patients
(92%) for a median time of 70 minutes (range, 6 to 194
minutes). Circulatory arrest with deep hypothermia was
used in 14 patients (11%). Available preoperative and post-
operative hemodynamic measurements are reported in Ta-
ble 3. The modifications of the Fontan procedure performed
are shown in Table 4. Associated cardiac procedures per-
TABLE 1. Diagnoses
Diagnosis n % of total
Tricuspid atresia 34 26
Double-inlet left ventricle 48 36
Complex 50 38
Double-outlet right ventricle 20
UVH, common AV valve 9
UVH, left AV valve atresia 7
UVH, right AV valve atresia 7
Hypoplastic right heart 3
Double-inlet right ventricle 2
Hypoplastic left heart 2
AV, Atrioventricular; UVH, univentricular heart.
TABLE 2. Prior palliative procedures*
Procedures n
Blalock-Taussig 85
Glenn 31
Pulmonary artery banding 20
Waterston 19
Potts 16
Exploration 5
Atrial septectomy 5
Pulmonary valvotomy 3
Subaortic resection 3
Central shunt 2
Damus-Stansel-Kaye 1
Brock 1
Atrial septal defect closure 1
Atrioventricular valve repair 1
None 14
Total 193
*Some patients had more than one procedure.
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formed at the time of the MFP, other than takedown of
shunts, atrial septal defect closures, and main pulmonary
artery closures, are listed in Table 5. Only 2 patients had an
atrial fenestration.
Overall early mortality was 8.3% (11 patients). Seven of
the deaths were cardiac in origin (Table 6). Other causes
included sepsis in 2, pulmonary hypertension in 1, and
pulmonary embolism in 1. Overall early mortality was 6.5%
(7/108) for operations performed after 1980. All 7 of the
early deaths since 1980 occurred in the complex lesion
group. There has been no early mortality in adult patients
with double-inlet left ventricle (n  36) or tricuspid atresia
(n  25) who were operated on after 1980. Univariate
analysis did not demonstrate any statistically significant risk
factors for early mortality (Table 7), although mean post-
operative right atrial pressure greater than 20 mm Hg (P 
.06) approached statistical significance. Of note, patients
with ventricular ejection fractions greater or equal to 50% or
atriopulmonary connections appeared to have less risk for
early mortality (P .06). Multivariate analysis could not be
performed due to the low number of events.
Median hospital stay was 15 days (range, 6 to 82 days).
Seventy-six of the 121 early survivors (63%) experienced
nonfatal postoperative morbidity (Table 8). The two most
common morbidities included prolonged pleural effusions
(30%) and atrial arrhythmias (21%). The two “Other” re-
operations were for repair of atrial septal defect patch de-
hiscence and removal of retained atrial pacing wires, re-
spectively.
The mean follow-up for the 121 hospital survivors was
9.1 years with a maximum of 21.2 years. Three foreign
patients were lost to follow-up. There were 32 known late
deaths, occurring from 1.1 months to 18 years after opera-
tion. The most common causes of late mortality were failure
of the univentricular circulation and arrhythmia (Table 9).
Kaplan-Meier survival, excluding early mortality, was 89%
(84,95), 75% (67,84), and 68% (58,79) at 5, 10, and 15
years, respectively (Figure 1). Survival stratified according
to initial diagnosis is shown in Figure 2. Univariate analysis
for late mortality is shown in Table 10. Significant risk
factors included preoperative mean pulmonary artery pres-
sure  15 mm Hg, male gender, age  30 years, and
postoperative right atrial pressure 20 mm Hg. Of interest,
patients who underwent an MFP with an atriopulmonary
connection were found to have a significantly lower risk of
late mortality. Significant risk factors by multivariate anal-
ysis are shown in Table 11.
Fifteen patients underwent late reoperation (Table 12).
No patient died at reoperation. Freedom from late reopera-
tion was 89% (83,95), 85% (78,93), and 81% (70,91) at 5,
10, and 15 years, respectively (Figure 3). Univariate anal-
ysis demonstrated operation prior to 1981 as a risk factor for
reoperation (P  .01). Multivariate analysis was not per-
formed due to too few reoperations.
Information on late complications was available in the
majority of hospital survivors (110 patients, 91%). Arrhyth-
mias were present in 46 patients (42%); 36 patients (33%)
had atrial arrhythmias. The initial operations in these 36
patients with late atrial arrhythmias included atriopulmo-
nary connection in 28 patients, lateral tunnel with atriopul-
monary connection in 3, right atrium-to-right ventricle con-
nection in 3, intra-atrial conduit in 1, and a Glenn shunt with
a right atrium-to-left pulmonary artery conduit in 1. Sixteen
patients (15%) had received permanent pacemakers second-
ary to chronotropic insufficiency or complete heart block,
including heart block resulting from catheter ablation. Other
late complications included protein-losing enteropathy in 8
patients, pleural effusion requiring thoracentesis in 7, and
cerebrovascular accident in 4 (none of the 4 were anticoag-
ulated). Of the 89 presently surviving patients, NYHA func-
TABLE 3. Pre- and postoperative hemodynamic variables
Variable n Mean  SD Median Range
Preoperative
Ejection fraction (%) 90 55 9.7 54 34-88
Right atrial pressure (mm Hg) 124 8.2 4.1 8 1-20
Pulmonary artery pressure
(mm Hg)
118 15 7.2 14 2-37
Postoperative
Right atrial pressure (mm Hg) 129 17 3.2 17 8-25
Left atrial pressure (mm Hg) 128 10 3.0 10 3-17
Transpulmonary gradient
(mm Hg)
128 7 2.7 7 2-15
TABLE 4. Type of modified Fontan connection
Connection n % of total
Atriopulmonary 74 56
Lateral tunnel 27 20
Atriopulmonary connection 22 17
Total cavopulmonary connection 5 4
Intra-atrial conduit 14 11
Right atrium-to-right ventricle 9 7
Extra-cardiac conduit 3 2
Other 5 4
TABLE 5. Additional procedures at time of the modified
Fontan procedure
Procedure n % of total
Right atrioventricular valve patch closure 44 33
Pulmonary artery patch angioplasty 17 13
Atrioventricular valve repair 10 8
Atrioventricular valve replacement 5 4
Aortic valve replacement 2 1.5
Atrial fenestration 2 1.5
Damus-Stansel-Kaye anastomosis 1 0.8
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tional class was available in 80 (90%). There were 33
patients (41%) in class I, 39 (49%) in class II, 7 (9%) in
class III, and 1 (1%) in class IV.
Discussion
Definitive palliation for anomalies with a single functional
ventricle, or two ventricles with anatomy that precludes
ventricular septation, has been successfully accomplished
by separation of the pulmonary and systemic circulations.1,2
Many modifications of the original procedures have been
made. Although the majority of the literature describes the
outcome of children undergoing an MFP, adult patients may
present with no or unsatisfactorily palliated single-ventricle
physiology. We have previously reported our results with a
small number of adult MFP patients from our early experi-
ence.5,6 This report examines the late results of all adult
patients who underwent MFP at our institution over a 28-
year period.
Our philosophy regarding patient selection has evolved
over the past 3 decades. Early in our experience, we recog-
nized that the criteria for operability suggested by Choussat
and Fontan were too strict and excluded patients who could
potentially be helped with an MFP.7 Accordingly, we lib-
eralized our criteria for selected patients.8,9 The previously
recommended upper limit of age (15 years) was exceeded in
TABLE 6. Cardiac causes of early death
Diagnosis
Age
(year) Operation
Surgery
(year)
Preop
PAP
Postop
RAP Death history
Complex 19 LT, APC 1987 13 18 Progressive heart failure, takedown Fontan
Complex 21 Intra-atrial conduit 1990 21 11 Morphologically right ventricle, cardiac failure
DILV 21 APC 1979 17 25 Difficulty coming off bypass, cardiac failure
TA 22 RA-PA, IVC valve 1976 7 17 Thrombosed IVC due to pulmonary HTN, cardiac failure
Complex 24 LT, TCPC 1990 35 16 Spontaneous dissection of right coronary artery ostium
Complex 29 LT, APC 1985 9 18 Anomalous hepatic veins, cyanosis, failure to come off bypass
Complex 35 LT, APC 1990 9 17 Morphologically right ventricle, cardiac failure
APC, Atriopulmonary connection; DILV, double-inlet left ventricle; HTN, hypertension; IVC, inferior vena cava; LT, lateral tunnel; PAP, mean pulmonary artery
pressure (mm Hg); RAP, mean right atrial pressure (mm Hg); RA-PA, right atrium-to-pulmonary artery conduit; TA, tricuspid atresia; TCPC, total
caval-pulmonary connection.
TABLE 7. Univariate analysis for early mortality
Variable
Hazard
ratio 95% CI
P
value
Ejection fraction  0.50 0.23 0.05-1.1 .06
Postoperative RAP  20 mm Hg 4.1 0.93-17.7 .06
Atriopulmonary connection 0.26 0.07-1.0 .06
MFP after 1980 0.35 0.09-1.3 .12
Postoperative LAP  10 mm Hg 2.4 0.60-9.4 .22
Prolonged pleural effusion 0.30 0.04-2.4 .26
Preoperative PAP  15 mm Hg 1.9 0.55-6.7 .30
Age  30 years 0.38 0.05-3.1 .37
Aortic crossclamp time  90 minutes 1.7 0.46-6.1 .44
Male 0.63 0.18-2.2 .46
CPB time  180 minutes 1.5 0.37-6.1 .56
NYHA functional class III or IV 1.8 0.21-14.6 .60
Preoperative RAP  10 mm Hg 0.73 0.15-3.7 .70
Previous surgery 1.2 0.14-10.2 .86
CI, Confidence interval; CPB, cardiopulmonary bypass; LAP, mean left atrial
pressure; MFP, modified Fontan procedure; NYHA, New York Heart Asso-
ciation; PAP, mean pulmonary artery pressure; RAP, mean right atrial
pressure.
TABLE 8. Early nonfatal morbidity
Complication n % of total
Prolonged pleural effusion 36 30
Atrial arrhythmias 25 21
Early reoperation 13 11
Bleeding 11 9
Other 2 1.7
Permanent pacemaker 8 7
Pneumonia 6 5
Renal failure 3 2.5
Cardiac arrest (surviving) 3 2.5
Tamponade 2 1.7
Cerebral vascular accident 2 1.7
Tracheostomy 1 0.8
Sternal wound infection 1 0.8
Gastrointestinal hemorrhage 1 0.8
Colitis 1 0.8
TABLE 9. Causes of late mortality
Cause n
Congestive heart failure 6
Sudden/arrhythmia 5
Protein-losing enteropathy 3
Sepsis 3
Pulmonary embolism 1
Inferior vena cava thrombosis 1
Tuberculosis 1
Appendectomy complication 1
Accident 1
Unknown 10
Total 32
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all patients in this review. The anatomical and cardiac
rhythm criteria of operability such as normal drainage of the
venae cavae, normal volume of the right atrium, no mitral
insufficiency, and sinus rhythm were also exceeded in many
patients. In addition, hemodynamic criteria regarding ven-
tricular function and mean pulmonary artery pressure were
exceeded in approximately half of the patients, as shown in
Table 3 (mean ventricular ejection fraction was 55%, and
mean pulmonary artery pressure was 15 mm Hg).
Most patients (85%) were in NYHA functional class III
or IV, and the vast majority were experiencing progressive
decrease in exercise tolerance and quality of life. Objective
progressive decline in ventricular function, decline in arte-
rial oxygen saturation, or increase in atrioventricular valve
regurgitation were other factors that were considered. Se-
lected deteriorating patients who were recognized to be at
significantly increased risk for operation and for whom no
other surgical options were available were offered operation
if it was thought there was a reasonable chance for their
survival and improvement, and some such patients had
excellent late results. However, it is still often difficult to
determine with confidence which adult patients who exceed
accepted criteria for operability might be benefited by an
MFP and which should not be offered operation. Elevated
Figure 1. Kaplan-Meier curve for survival excluding early mor-
tality. n  number of patients at risk.
Figure 2. Kaplan-Meier curves for survival, excluding early mor-
tality, divided into diagnoses: tricuspid atresia (solid line), dou-
ble-inlet left ventricle (dotted line), and complex (dashed line).
There was no statistically significant difference in the 15-year
survival between the groups. n  number of patients at risk.
TABLE 10. Univariate analysis for late mortality
Variable
Hazard
ratio 95% CI P value
Preoperative PAP  15 mm Hg 3.8 1.7-8.4 .001
Male 2.8 1.2-6.6 .01
Age  30 years 2.3 1.1-4.8 .04
Postoperative RAP  20 mm Hg 2.4 0.99-6.0 .05
APC 0.5 0.25-1.0 .05
NYHA functional class 3 or 4 4.6 0.63-34 .13
Preoperative RAP  10 mm Hg 1.7 0.83-3.7 .14
CPB time  180 minutes 1.8 0.79-4.0 .16
Fontan after 1980 0.61 0.29-1.3 .21
Prolonged pleural effusion 1.4 0.67-2.8 .39
Transpulmonary gradient  10 mm Hg 1.5 0.46-5.1 .48
Postoperative LAP  10 mm Hg 1.3 0.56-2.8 .52
Aortic crossclamp time  90 minutes 1.2 0.54-2.7 .66
Previous surgery 1.2 0.36-3.9 .77
Ejection fraction  0.50 0.87 0.30-2.5 .79
APC, Atriopulmonary connection without lateral tunnel; CI, confidence
interval; CPB, cardiopulmonary bypass; LAP, mean left atrial pressure;
NYHA, New York Heart Association; PAP, mean pulmonary artery pressure;
RAP, mean right atrial pressure.
TABLE 11. Multivariate analysis of risk factors for late
mortality
Variable
Hazard
ratio 95% CI P value
Preoperative PAP  15 mm Hg 3.5 1.5-8.1 .0005
Age  30 years 2.9 1.2-6.7 .01
Male gender 3.4 1.2-10.1 .03
CI, Confidence interval; PAP, mean pulmonary artery pressure.
TABLE 12. Late reoperations
Procedure n
Repair tricuspid valve patch dehiscence 4
Revision of stenotic RA-PA connection 4
Atrioventricular valve replacement 2
Conversion APC to lateral tunnel with APC 1
Conversion to unvalved 1.5 ventricle repair; cryomaze 1
Removal of infected epicardial pacemaker leads 1
Revision of SVC-RA anastomosis 1
Removal of thrombosed intra-atrial (hepatic veins)
conduit
1
Total 15
APC, Atriopulmonary connection; RA-PA, right atrium-to-right ventricle;
SVC-RA, superior vena cava-to-right atrium.
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pulmonary arteriolar resistance and severe systolic and di-
astolic ventricular dysfunction have been found to be the
most important contraindications to the MFP.8,9 In general,
the indications and criteria employed for adults in this series
were the same as for children at our institution.
Early mortality was 8.3% for the entire group of 132
patients. Over half of the early deaths were due to cardiac
causes. The early mortality declined after 1980 to 6.5%.
Similar early mortality rates ranging from 5% to 13% have
been reported in adult MFP patients.10-12 Of note is that the
mortality of our adult series is comparable to mortality of
the MFP performed in children at our institution as well as
other institutions.13-16 Mair and coworkers reported an early
mortality of 9% in a cohort of patients, the majority of
whom (88%) were 19 years old or younger.13 All 7 of the
early deaths since 1980 in the present study occurred in
patients with complex anatomy; there was no early mortal-
ity in adult patients with double-inlet left ventricle (n  36)
or tricuspid atresia (n  25). Overall in this study, there has
been only 1 early death in all 34 patients (2.9%) with a
diagnosis of tricuspid atresia.
Important postoperative morbidity occurred in 63% of
the patients. The most common was chest tube drainage
longer than 14 days, occurring in 30%. We and others have
reported similar postoperative pleural effusion rates in chil-
dren and adults.11,17 Many of our patients were operated on
prior to the introduction of the fenestration concept. Nev-
ertheless, we apply the fenestration selectively for patients
with findings that the attending cardiologist and surgeon
anticipate will increase the probability for postoperative
morbidity or mortality, especially if hemodynamics are bor-
derline at the conclusion of the MFP. If a fenestration is
performed in an adult patient, warfarin anticoagulation is
usually recommended. The long-term risks associated with
chronic right-to-left shunting, thrombus formation, and po-
tential paradoxical embolism have been the major concerns
associated with fenestration, especially in adult patients.17
In addition, there is the decrease in exercise tolerance, and
consequently quality of life, in fenestrated patients with
arterial desaturation.
The second most common postoperative morbidity was
atrial arrhythmias, occurring in 21% of the patients. This is
consistent with other mixed-aged cohorts showing a 10% to
20% incidence of atrial arrhythmias in the postoperative
period.18-20 Of note is that 16 of the 25 patients who
experienced atrial arrhythmias had an atriopulmonary con-
nection without lateral tunnel. Newer MFP modifications
such as the extracardiac conduit MFP, which has fewer
atrial suture lines as well as decreased atrial wall tension,
may reduce the incidence of this postoperative arrhythmias.
However, extracardiac conduits in the pulmonary ventricle-
to-pulmonary artery position are known to have a high
incidence of late complications, especially stenosis. The late
results of the extracardiac MFP remain to be determined.
The development of late atrial arrhythmias continues to
be a significant problem following the MFP. One third of
our patients at late follow-up had been or were being treated
for atrial arrhythmias. Veldtman and colleagues and Gates
and coworkers reported late atrial arrhythmias in 46% and
37%, respectively in adult patients undergoing the
MFP.10,11 Late follow-up on large numbers of patients will
be necessary to demonstrate which of the many MFP mod-
ifications will give the lowest incidence of this important
complication.20
Four patients had late cerebrovascular accidents, none of
whom were on warfarin. Anticoagulation after an MFP
continues to be a topic of controversy.21 In general, we tend
to anticoagulate most adult patients, particularly those with
a fenestration or those with a history of arrhythmias, intra-
cardiac thrombus, slow circulation, and venous varices. In
the asymptomatic young adult patient, we may substitute
aspirin.
Late survival, excluding early mortality, was 89%, 75%,
and 68% at 5, 10, and 15 years, respectively. These results
are similar to the 61 adult patient series by Veldtman and
colleagues in which survival rates of 76%, 72%, and 67%
were reported at 5, 10, and 15 years, respectively.10 These
results are also similar to results of series primarily com-
prised by pediatric patients as reported by our institution
and others.8,22 Risk factors for late mortality included pre-
operative mean pulmonary artery pressures greater than 15
mm Hg, age greater or equal to 30 years, and male gender.
Hemodynamic risk factors in this series were similar to
those patients of all ages undergoing the MFP.9,23
From the standpoint of symptoms, a marked improve-
ment was noted in most of these adult patients postopera-
tively. Prior to the MFP, 85% of patients were in NYHA
functional class III or IV. At long-term follow-up, 90% of
survivors were NYHA class I or II. Other series have shown
similar results.10,11
Figure 3. Curve showing freedom from late reoperation in early
survivors. n  number of patients at risk.
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In conclusion, the MFP can be performed with low early
mortality in properly selected adult patients with functional
single ventricle. Early mortality is more likely with complex
lesions. Late survival is good and similar to results reported
in children. The majority of late survivors enjoy a good
quality of life.
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Discussion
Dr T. Spray (Philadelphia, Pa). I compliment the authors of
this excellent paper on their presentation of a large series of adult
patients who underwent Fontan reconstruction for variations of
single-ventricle anatomy over a 28-year period in a single institu-
tion. The authors have shown very nicely that the Fontan operation
can be performed in adult patients with excellent outcomes and
improvement in functional status, with mortality and complication
rates that are only slightly higher than those seen in the pediatric
population. Obviously, patient selection has much to do with the
excellent outcomes presented and therefore I have several ques-
tions for the authors.
Patients who came to the Fontan completion in this series had
class 3 or class 4 symptoms. I assume that most patients had
symptoms primarily related to progressive cyanosis rather than
heart failure. There have been some centers that have recom-
mended leaving patients with a Glenn anastomosis and not pro-
ceeding to a Fontan completion operation, especially in adults.
Your data would suggest that these patients eventually become
cyanotic enough to require a Fontan completion. Could you com-
ment on your institutional philosophy regarding the timing of and
indications for the completion operation in adult patients?
It is particularly interesting to note that in the series presented,
the majority of patients underwent atrial pulmonary operations and
relatively fewer adults had the lateral tunnel modification. Only 3
patients in the series underwent an extracardiac completion oper-
ation, even though this approach has been preferred in many
centers for as long as 10 years and would seem to be ideally suited
for those patients who had a previous Glenn anastomosis. Could
you comment on why the extracardiac approach has not been used
more commonly in your patient population? Is the lateral tunnel
technique still the preferred operation at the Mayo Clinic?
Prolonged pleural effusions greater than 2 weeks in duration
were noted in about 30% of the adult population that you pre-
sented. Fenestration of the Fontan baffle, however, was only uti-
lized in 2 patients in the series, and yet if cyanosis was the primary
indication for operation, a fenestration would still have permitted
improvement in oxygen saturation postoperatively and would
likely have limited the duration and severity of postoperative
effusions.
In your manuscript, which you kindly provided for me prior to
this discussion, it was noted that fenestration was used in patients
with mild elevation in pulmonary resistance or mildly decreased
ejection fraction. Could you elaborate more on what is considered
mild elevation of pulmonary resistance or a decrease in ventricular
function, considering that the significant majority of your patients
had a functional single left ventricle? Would patients with right
ventricular morphology have different indications for the complete
Fontan operation in your institution in adulthood, and would
fenestrations be more commonly used in that patient population?
Surgery for Congenital Heart Disease Burkhart et al
1258 The Journal of Thoracic and Cardiovascular Surgery ● June 2003
CH
D
